Skip To Content

Clinical Research Services

Clinical Research at CaroMont Health is comprised of two departments:

  • Office of Research Administration
  • Accreditation & Regulatory Affairs / Institutional Review Board (IRB)

Clinical research is subject to the regulations of the Food and Drug Administration (FDA), and follows ethical and professional guidelines, including Good Clinical Practice (GCP).

CaroMont Health currently has ongoing clinical trials in oncology offered through the CaroMont Cancer Center and CaroMont Hematology and Oncology.

CaroMont Health Human Research Protection Program

Protecting the rights, safety and welfare of research participants at CaroMont Health is our main priority. To accomplish this, CaroMont Health has in place a Human Research Protection Program (HRPP) as we strive to exceed the highest standards in clinical research.

Current, former, or potential research participants can contact the following with questions or concerns regarding research at CaroMont Health. Research compliance-related questions or concerns can also be addressed to the following.

Research personnel are expected to report any known or suspected noncompliant conduct related to research conducted at CaroMont Health. The confidential CaroMont Health Corporate Compliance Hotline (877.785.0001) is available for any individual that wishes to remain anonymous and/or has found other reporting mechanisms to be ineffective.

Institutional Review Board

The CaroMont Health Institutional Review Board (IRB) is a federally mandated body established under the DHHS and FDA regulations for the Protection of Human Subjects (45 CFR 46 and 21 CFR 56).

Research Administration

The Office of Research Administration is responsible for the conduct of clinical research trials at CaroMont Health, including training and education.

Research Participants

Find resources for research participants, websites about participating in clinical trials, contact information, questions and more.